Externally indexed torrent

If you are the original uploader, contact staff to have it moved to your account

Textbook in PDF format

Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics. This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It addresses future trends in the biosimilars market.
Biosimilars - A Regulatory and Clinical Perspective
Biosimilars in Inflammatory Bowel Diseases: General Concepts and Clinical Implications
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life
Monoclonal Antibodies for Cancer Treatment
Biosimilar Monoclonal Antibodies in Latin America